Congress trades in Athira Pharma (ATHA)
Healthcare · Biotechnology
1 member of Congress has disclosed 1 trade in Athira Pharma (ATHA) since 2022: 1 buy and 0 sales. The most recent was disclosed on Jan 20, 2023.
- Trades disclosed
- 1
- Members trading
- 1
- Buys / sells
- 1 / 0
- Reported value
- $1K–$15K
Who traded ATHA
MemberBuysSalesLast disclosed
- Rep. Chris Jacobs (R-NY-27)1 buy · 0 sales10Jan 20, 2023
All trades
DisclosedTradeAmount
- Jan 20, 2023$1K–$15K
Rep. Chris Jacobs (R-NY-27)
$1K–$15K · Traded Dec 12, 2022 · disclosed Jan 20, 2023
From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.